CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will not be presenting at the Bank of America 2008 Specialty Pharmaceuticals Conference on August 8, 2008, as previously scheduled. The company’s planned update on its scientific platform and delivery approaches will be presented at another investor conference in the near future.
